Trafficking dynamics of VEGFR1, VEGFR2, and NRP1 in human endothelial cells

被引:4
|
作者
Sarabipour, Sarvenaz [1 ,2 ]
Kinghorn, Karina [3 ,4 ]
Quigley, Kaitlyn M. [4 ]
Kovacs-Kasa, Anita [5 ,6 ]
Annex, Brian H. [5 ,6 ]
Bautch, Victoria L. [3 ,4 ,7 ]
Mac Gabhann, Feilim [1 ,2 ]
机构
[1] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA
[3] Univ N Carolina, Curriculum Cell Biol & Physiol, Chapel Hill, NC USA
[4] Univ N Carolina, Dept Biol, Chapel Hill, NC USA
[5] Augusta Univ, Vasc Biol Ctr, Med Coll Georgia, Augusta, GA USA
[6] Augusta Univ, Dept Med, Med Coll Georgia, Augusta, GA USA
[7] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA
关键词
GROWTH-FACTOR; THERAPEUTIC ANGIOGENESIS; RECEPTOR; ENDOSOME; DOMAIN; NEUROPILIN-1; MECHANISMS; VESICLES; PATHWAY; MODEL;
D O I
10.1371/journal.pcbi.1011798
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The vascular endothelial growth factor (VEGF) family of cytokines are key drivers of blood vessel growth and remodeling. These ligands act via multiple VEGF receptors (VEGFR) and co-receptors such as Neuropilin (NRP) expressed on endothelial cells. These membrane-associated receptors are not solely expressed on the cell surface, they move between the surface and intracellular locations, where they can function differently. The location of the receptor alters its ability to 'see' (access and bind to) its ligands, which regulates receptor activation; location also alters receptor exposure to subcellularly localized phosphatases, which regulates its deactivation. Thus, receptors in different subcellular locations initiate different signaling, both in terms of quantity and quality. Similarly, the local levels of co-expression of other receptors alters competition for ligands. Subcellular localization is controlled by intracellular trafficking processes, which thus control VEGFR activity; therefore, to understand VEGFR activity, we must understand receptor trafficking. Here, for the first time, we simultaneously quantify the trafficking of VEGFR1, VEGFR2, and NRP1 on the same cells-specifically human umbilical vein endothelial cells (HUVECs). We build a computational model describing the expression, interaction, and trafficking of these receptors, and use it to simulate cell culture experiments. We use new quantitative experimental data to parameterize the model, which then provides mechanistic insight into the trafficking and localization of this receptor network. We show that VEGFR2 and NRP1 trafficking is not the same on HUVECs as on non-human ECs; and we show that VEGFR1 trafficking is not the same as VEGFR2 trafficking, but rather is faster in both internalization and recycling. As a consequence, the VEGF receptors are not evenly distributed between the cell surface and intracellular locations, with a very low percentage of VEGFR1 being on the cell surface, and high levels of NRP1 on the cell surface. Our findings have implications both for the sensing of extracellular ligands and for the composition of signaling complexes at the cell surface versus inside the cell. Receptors and their ligands are at the heart of cell-to-cell signaling, but can only interact if they are in the same place at the same time. This is controlled in part by expression-only if a cell expresses a receptor can the cell perceive and respond to that ligand. But it is also controlled in part by where in the cell that receptor is. If the receptor is on the cell surface, it may be able to bind extracellular ligands. If inside the cell, e.g. on endosomal vesicles, it may not. Similarly, the intracellular portions of receptors at the cell surface and inside the cell are exposed to different local environments and can initiate different signaling pathways. Therefore, understanding receptor localization and trafficking (how the receptors move within the cell) is an important starting point for understanding receptor function. Here, we use mechanistic computational modeling and quantitative experimental data to define the localization and trafficking of the VEGF receptors, which are key drivers of blood vessel growth and remodeling. We show that these receptors each has different trafficking and patterns of localization, which has significant implications for the differential responses of these receptors to extracellular ligands.
引用
收藏
页数:28
相关论文
共 50 条
  • [21] Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer
    Maryam Farzaneh Behelgardi
    Saber Zahri
    Zahra Gholami Shahvir
    Farhad Mashayekhi
    Laleh Mirzanejad
    S. Mohsen Asghari
    Molecular Biology Reports, 2020, 47 : 2061 - 2071
  • [22] VEGFR1 and VEGFR2 immunohistochemical expression in oral squamous cell carcinoma: a morphometric study
    Stinga, A. C.
    Margaritescu, Otilia
    Stinga, Alina Simona
    Pirici, D.
    Ciurea, Raluca
    Bunget, Adina
    Cruce, M.
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2011, 52 (04): : 1269 - 1275
  • [23] VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation
    Herzog, Birger
    Pellet-Many, Caroline
    Britton, Gary
    Hartzoulakis, Basil
    Zachary, Ian C.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22 (15) : 2766 - 2776
  • [24] Simultaneous inhibition of VEGFR1 and VEGFR2 signaling is required for suppression of experimental melanoma metastases
    Boehme, B
    Aicher, A
    Gaumann, A
    Hicklin, DJ
    Bohlen, P
    Dimmeler, S
    Kaufmann, R
    Breier, G
    Gille, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (02)
  • [25] Computational Modeling to Quantify the Contributions of VEGFR1, VEGFR2, and Lateral Inhibition in Sprouting Angiogenesis
    Kuehn, Clemens
    Checa, Sara
    FRONTIERS IN PHYSIOLOGY, 2019, 10
  • [26] Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer
    Farzaneh Behelgardi, Maryam
    Zahri, Saber
    Gholami Shahvir, Zahra
    Mashayekhi, Farhad
    Mirzanejad, Laleh
    Asghari, S. Mohsen
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (03) : 2061 - 2071
  • [27] Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling
    Jacobsen, Kimberly A.
    Al-Aql, Zainab S.
    Wan, Chao
    Fitch, Jennifer L.
    Stapleton, Stephanie N.
    Mason, Zachary D.
    Cole, Robert M.
    Gilbert, Shawn R.
    Clemens, Thomas L.
    Morgan, Elise F.
    Einhorn, Thomas A.
    Gerstenfeld, Louis C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (05) : 596 - 609
  • [28] Simultaneous inhibition of VEGFR1 and VEGFR2 signaling is required for suppression of experimental melanoma metastases
    Boehme, B
    Aicher, A
    Spieth, K
    Gaumann, A
    Hicklin, DJ
    Bohlen, P
    Dimmeler, S
    Kaufmann, R
    Breier, G
    Gille, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A1 - A1
  • [29] MIRO1 MAINTAINS MITOCHONDRIAL DYNAMICS & VEGFR2 SIGNALING IN ENDOTHELIAL CELLS
    Najar, Rauf A.
    Millar, Michelle W.
    Shadab, Mohammad
    Fazal, Fabeha
    Rahman, Arshad
    SHOCK, 2024, 62 (01): : 71 - 72
  • [30] VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1-and Galectin-3-Induced Angiogenesis
    D'Haene, Nicky
    Sauvage, Sebastien
    Maris, Calliope
    Adanja, Ivan
    Le Mercier, Marie
    Decaestecker, Christine
    Baum, Linda
    Salmon, Isabelle
    PLOS ONE, 2013, 8 (06):